No abstract available.
Vitamin K Deficiency* ; Vitamin K* ; Vitamins*

No abstract available.
Vitamin K Deficiency* ; Vitamin K* ; Vitamins*

No abstract available.
Vitamin K* ; Vitamins*

No abstract available.
Diagnosis* ; Intracranial Hemorrhages* ; Vitamin K Deficiency* ; Vitamin K* ; Vitamins*

No abstract available.
Diagnosis* ; Intracranial Hemorrhages* ; Vitamin K Deficiency* ; Vitamin K* ; Vitamins*

No abstract available.
Humans ; Infant, Newborn* ; Vitamin K Deficiency* ; Vitamin K* ; Vitamins*

Background: Intracranial hemorrhage (lCH) is a common disease with high rate of mortality and neurological sequel. Objectives:to estimate preventive effectiveness of intracranial hemorrhage by vitamin K1 and K3 for newborns just after birth". Subjects and methods: An epidemiological, randomized control study with intervention was conducted. The study included all children under 3 months with and without ICH during period 1/1/2000 -30/6/2004 living in Hatay province. Among them all the newborns during period 1/6/2002 - 30/6/2004 were injected either 1 mg vitamin K1 or K3. Results: Children injected with vitamin K in the intervention period were followed up in three months and evaluated by a united process. Effects of intervention were calculated by preventive value. 62.057/82069 newborns were injected vitamin K1 or Vitamin K3 (25.725 newborns were injected Vitamin K1; 36.332 newborns were injected vitamin K3). Single dose 1M reduced the rate of ICH in infants: The morbidity changed from 3.3\ufffd?to 0.82\ufffd? the prevention value was 96%. There were no complications and side effects of vitamin K injections reported. Conclusions: Injection of vitamin K1 and K3 have similar preventive effectiveness. Vitamin K injection 1M with recommended dose was safe for newborns.\r\n', u' \r\n', u'\r\n', u'
Intracranial Hemorrhages ; Vitamin K Deficiency

The periprocedural management of patients on long-term antithrombotic therapy (antiplatelet agents or vitamin K antagonists) who may require temporary disruption, given that an invasive procedure is always a dilemma for clinicians. Discontinuation of antithrombotic therapy can place patients at an increased risk of thromboembolic complications while the continuation of antithrombotic therapy can increase the procedure-related bleeding risk. Therefore, it is imperative for clinicians to be proficient in making thoughtful and individualized decisions on the appropriate management of periprocedural anticoagulants, drawing from recent evidence-based guidelines.
Anticoagulants ; Hemorrhage ; Heparin ; Humans ; Vitamin K

Spontaneous intramural intestinal hematoma is a rare complication resulting from over-anticoagulation. We report on three uncommon cases of spontaneous intramural small bowel hematoma due to oral anticoagulation. The patients received conservative treatment with bowel rest, hydration and vitamin K infusion, and transfusion of fresh frozen plasma (FFP). Computed tomography (CT) scan was performed for diagnostic confirmation. Patients recovered within a few days. Because there are no specific symptoms or clinical signs, diagnosis of this condition is difficult. Therefore, clinical suspicion and experience are important. This case report represents an attempt to share information on this rare condition by presentation of the case and literature review.
Hematoma ; Humans ; Intestine, Small ; Plasma ; Vitamin K

Vitamin K ; Pregnant Women ; Pregnancy ; Urban Population